| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
CASI Pharmaceuticals, Inc.
13D/A
CASIF · G1933S101
|
5.0% |
1/20/2026
Event 9/30/2025
|
||||
| Sparkle Byte Ltd | 5.0% | |||||
| Snow Moon Ltd | 5.0% | |||||
| Tianjin Jingran Management Center (Limited Partnership) | 5.0% | |||||
| Beijing Hexie Kangjian Investment Center (Limited Partnership) | 5.0% | |||||
| Beijing Hexie Tiancheng Investment Management Center (Limited Partnership) | 5.0% | |||||
| He Xie Ai Qi Investment Management (Beijing) Co., Ltd. | 5.0% | |||||
| Xizang Hexie Enterprise Management Co., Ltd. | 5.0% | |||||
| Zhuhai Hexie Zhiyuan Management Consulting Co., Ltd. | 5.0% | |||||
| Jianguang Li | 5.0% | |||||
| Dongliang Lin | 5.0% | |||||
| Jingbo Wang | 5.0% | |||||
| Kuiguang Niu | 5.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.